Categories: Human Body

The Johnson & Johnson Vaccine Just Recorded Another Rare Blood Clotting Case

© Shutterstock

Also, this rare condition seems to affect mostly women aged under 60. Unfortunately, one of them lost her life while the others were severely ill. However, the first blood clotting case in a man has just been reported.

There’s still a lot to learn about COVID-19 vaccine side effects because even though millions of people are safely immunized, others have had a rough experience with it.

Related Post

Just like AstraZeneca is very controversial in the European Union, so is the Johnson & Johnson vaccine in the United States, as both have been linked to causing blood clots. Even though blood clotting is considered a rare occurrence, and there’s less than one in a million chances of developing this condition, the truth is most people are still worried about their safety, and for a good reason.

Here’s Everything You Need to Know About Johnson & Johnson’s Vaccine. CLICK HERE to find out more!

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Recent Posts

5 Gadgets That Changed Our Everyday Lives For Good

Before you read this article, we want to ask you something. How many gadgets do you use on a daily…

10 Signs Your Phone Might Be Hacked

We have to admit that nowadays, it seems like we are not able to get our phones out of our…

10 Surprising Things That Are Made From Human Body Parts

As we all know, some of us will check out the labels on the majority of the things we use…

What is Flurona? It Might Be Even More Dangerous Than Covid-19, Experts Say

Covid-19 is a strong virus that has the ability to change extremely quickly and develop into something even more dangerous…

FDA Recommends Covid Antiviral Pills, But Doctors Disagree

Over the past years, there have been a lot of discussions regarding the SARS-CoV-2 pandemic that have emerged. The main…

Omicron Variant Might Cause Another COVID Wave, Doctors Say

We already know that Covid-19 has a new variant, called Omicron. We know that it is twice as dangerous as…